Roughly 70 percent of new drugs currently in development are classified as poorly soluble. This means your body may not fully process the active pharmaceutical ingredient and a large percentage of the medication will simply pass through your system.
Ashland is working on new products that will help improve the effectiveness of pills and tablets, which account for two-thirds of all prescriptions. We’re a global leader in binders, which help form the tablet, and in disintegrants, which enable fast release of the active ingredient into your body.
Click here to learn more about our support for the pharmaceutical industry.
Click here to learn about the innovation that leads to product breakthroughs.